Brand Name | Status | Last Update |
---|---|---|
e l f camo semi matte cc spf 30 light 205 n | C200263 | 2024-11-06 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Multiple myeloma | D009101 | — | C90.0 | 2 | 12 | 4 | — | — | 18 |
Plasma cell neoplasms | D054219 | — | — | 1 | 12 | 4 | — | — | 17 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Immunoglobulin light-chain amyloidosis | D000075363 | — | — | 2 | 1 | — | — | — | 2 |
Amyloidosis | D000686 | EFO_1001875 | E85 | 2 | 1 | — | — | — | 2 |
Smoldering multiple myeloma | D000075122 | — | — | — | 1 | — | — | — | 1 |
Renal insufficiency | D051437 | — | N19 | — | 1 | — | — | — | 1 |
Recurrence | D012008 | — | — | — | 1 | — | — | — | 1 |
Leiomyosarcoma | D007890 | — | — | — | 1 | — | — | — | 1 |
Liposarcoma | D008080 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | — | 2 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | — | — | — | — | 1 |
Drug common name | Calcium dobesilate |
INN | calcium dobesilate |
Description | Calcium dobesilate is a vasoprotective. It is the calcium salt of dobesilic acid.
It is a synthetic molecule with the ability to reduce capillary permeability in the body. In Switzerland the drug is sold by the pharmaceutical company OM Pharma under the trade name of Doxium in capsules containing 500Â mg of active ingredient.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=S(=O)([O-])c1cc(O)ccc1O.O=S(=O)([O-])c1cc(O)ccc1O.[Ca+2] |
PDB | — |
CAS-ID | 117552-78-0 |
RxCUI | — |
ChEMBL ID | CHEMBL2106191 |
ChEBI ID | — |
PubChem CID | 29963 |
DrugBank | DBSALT002519 |
UNII ID | 5921X1560Q (ChemIDplus, GSRS) |